Futoshi Kurimoto

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 626 citations

Interim Analysis, Oncology, Bevacizumab Versus Erlotinib +8

Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line

Akihiko Gemma, K. Takenaka, Yoko Hosoya et al. · European Journal of Cancer · 2001 · 91 citations

Altered Expression, Metastatic Subpopulations, Tumor Heterogeneity +11

Atrial natriuretic peptide distribution in fetal and failed adult human hearts.

Hidetsugu Tsuchimochi, Futoshi Kurimoto, Keiko Ieki et al. · Circulation · 1988 · 60 citations

Cardiac Muscle, Right Atrium, Heart Failure +18

Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers

Akihiko Gemma, Yoko Hosoya, Masahiro Seike et al. · Lung Cancer · 2001 · 42 citations

Somatic Variant, Oncogenic Agent, Human Mad2 Gene +9

Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer

Masahiro Ando, Kunihiko Kobayashi, Akinobu Yoshimura et al. · Lung Cancer · 2003 · 35 citations

Oncology, Medicine, Cancer Management +6